Found 60 matching trials
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
PHASE3This is an open-label extension study to Study 200622.In this study subject...
Location
GSK Investigational Site
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
PHASE4The purpose of this study is to investigate the feasibility of extending th...
Location
Dept of otorhinolaryngology, Aalborg University Hospital
Mepolizumab in Episodic Angioedema With Eosinophilia
PHASE2Background:
Gleich syndrome is also called episodic angioedema with eosino...
Location
National Institutes of Health Clinical Center
Study of Mepolizumab Safety Syringe in Asthmatics
PHASE3This study is aimed to assess the correct real-world use of a safety syring...
Location
GSK Investigational Site
Residual Exacerbations With Mepolizumab
N/AThis will be a two-year prospective study to characterize the nature of the...
Location
Institut universitaire de cardiologie et de pneumologie de Québec
Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor Initiation
N/AEosinophilic inflammation in the small airways of patients with severe asth...
Location
External Unit of Asthma of Respiratory Medicine Department of the University of Thessaly in Greece
Immunological Basis for Mepolizumab Activity in COPD
PHASE2The current literature suggests that the mode of action of mepolizumab is t...
Location
Multiple Locations
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE4The goal of this randomized clinical trial is to compare the effects of two...
Status
Active Not Recruiting
Location
Aalborg Universitetssygehus Syd
Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
N/AThe primary objective of the study is to measure the effect of mepolizumab ...
Location
University Hospital Grenoble
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
PHASE3This is a multi-centre, placebo-controlled, double-blind, parallel-group st...
Location
GSK Investigational Site